Berzelii Pharma AB

ABActive

Org 5594833427Research and experimental development on natural sciences and engineering· NACE 7210Est. 2024 · 2 years old1-4 employees

Overview Financials People & ownership Related companies

Berzelii Pharma AB is a Swedish AB, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2024.

Revenue 2024

—

EBITDA margin

—

Net profit 2024

SEK -67K

Key ratios

See full ratios →

55.1%

This company

20242024

2.2×

This company

20242024

-64.6%

This company

20242024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	—	—
EBITDA	SEK -67K	—
Net profit	SEK -67K	—
Total assets	SEK 104K	—
Equity	SEK 58K	—
Employees	—	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Berzelii Pharma AB?

Berzelii Pharma AB is registered with Bolagsverket / SCB under Org 5594833427.

Who is the CEO of Berzelii Pharma AB?

Hans Marcus Bosson is the CEO of Berzelii Pharma AB, in role since 2025.

Who is the chairman of Berzelii Pharma AB?

Hans Henrik von Celsing chairs the board of Berzelii Pharma AB, in role since 2025.

Berzelii Pharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Berzelii Pharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Berzelii Pharma AB